Study shows need for educating patients on lens care, follow-up

Article

Noncompliance with lens care instructions represents the primary risk factor for contact lens case contamination, according to results from a recent study.

Anastasopoulos is research operations manager, Clinical Vision Research Australia, Australian College of Optometry, Melbourne.

The time course of contamination of contact lens cases used by patients in daily wear of senofilcon-A silicone hydrogel lenses and factors predicting contamination were investigated in a large, prospective, masked study.

The study enrolled 132 subjects fitted with 2-week replacement senofilcon A contact lenses. Of the two lens care solutions used, one product was preserved with polyquaternium-1 and myristamidopropyl dimethylamine (MAPD) and the other with polyhexamethylene biguanide (PHMB). Both were used in a rinse-only regimen.

Unannounced inspections

About 40 patients in each of the three follow-up groups completed the study. When they returned for follow-up, specimens from both the contact lens cases and lenses were cultured for bacteria, although the patients were not told at enrollment that cultures would be performed.

The level of contamination was graded on a 5-point scale where 0 = nil and 4 represented >300 CFU/ml. Noncompliance with various care instructions was assessed via a questionnaire and an overall noncompliance score was also calculated.

Within the group of patients who returned after 7 days, 56% of contact lens cases showed some level of bacterial contamination. However, there were no significant differences in contamination rates between follow-up groups or between the two lens care solutions at any follow-up visit.

Rates of moderate to heavy contamination were higher in the 14- and 30-day follow-up groups, but the differences compared with the 7-day follow-up group were not statistically significant, Anastasopoulos reported.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.